| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |